Colibacillosis (E. coli scours)

Colibacillosis, commonly known as E. coli scours, represents one of the most significant infectious diseases affecting neonatal livestock worldwide, caused by pathogenic strains of the bacterium Escherichia coli. This condition manifests primarily as severe diarrhea in young animals during their first days to weeks of life, though systemic infection and septicemia may also occur depending on the E. coli strains involved and the animal's immune status. The disease causes substantial economic losses across cattle, sheep, goat, swine, and poultry operations through mortality, treatment costs, reduced growth rates, and long-term impacts on surviving animals.

The condition predominantly affects neonatal animals that have not received adequate passive immunity through colostrum ingestion, making the first hours and days of life the highest risk period. Calves under two weeks of age are most commonly affected, with peak incidence during the first week when maternal antibody protection is critical for survival. Lambs, kids, and piglets face similar vulnerability during their early neonatal period. In poultry, colibacillosis can affect birds of various ages but commonly causes significant losses in young chicks and growing birds under stressful conditions. The consistent pattern of young animal susceptibility emphasizes the critical importance of colostrum management and hygiene in disease prevention.

Economic and welfare implications of colibacillosis are substantial and extend far beyond individual animal losses. Mortality rates in outbreaks can exceed fifty percent of affected animals without aggressive treatment, representing significant direct losses to producers. Surviving animals often experience prolonged recovery periods with reduced growth rates and increased susceptibility to secondary infections. Treatment costs including antibiotics, fluids, and labor accumulate rapidly during outbreak situations. The suffering of affected animals experiencing profuse diarrhea, dehydration, and systemic illness raises significant welfare concerns that demand both prevention focus and prompt treatment response.

Fortunately, colibacillosis responds to appropriate antibiotic therapy when treatment begins early, and comprehensive prevention through colostrum management, environmental hygiene, and vaccination programs can dramatically reduce disease incidence. Understanding the pathogenic mechanisms of different E. coli types guides both treatment and prevention approaches. Early recognition of clinical signs combined with aggressive fluid therapy and appropriate antimicrobials provides the best outcomes for affected individuals. However, the primary goal should be prevention through management practices that ensure adequate passive immunity transfer and minimize pathogen exposure during the vulnerable neonatal period.

The primary cause of colibacillosis is infection with pathogenic Escherichia coli strains that possess specific virulence factors enabling them to cause disease. Not all E. coli are pathogenic; indeed, commensal E. coli populate the intestinal tract of healthy animals without causing harm. Pathogenic strains are categorized based on their mechanisms of disease causation, including enterotoxigenic E. coli (ETEC) that produce toxins causing secretory diarrhea, enteropathogenic E. coli (EPEC) that attach to and damage intestinal cells, and septicemic strains that invade the bloodstream to cause systemic infection. Understanding these different pathotypes helps explain the varying clinical presentations and guides prevention strategies.

Genetic susceptibility to colibacillosis relates primarily to individual variation in intestinal receptor expression that influences bacterial attachment and colonization. Some animals may possess intestinal cell surface structures that more readily bind E. coli adhesins, particularly the F5 (K99) fimbriae common in calf-pathogenic strains. While not strictly hereditary in terms of simple genetic transmission, this variation in receptor expression means some individuals within a group may be more susceptible than others facing identical exposure. Research into genetic markers for resistance continues, though practical selection for colibacillosis resistance is not currently implemented in commercial breeding programs.

Environmental and management factors play crucial roles in colibacillosis occurrence, often determining whether endemic pathogenic strains cause clinical outbreaks. Contaminated calving or farrowing environments serve as primary sources of neonatal infection, with pathogenic E. coli surviving in fecal material, bedding, and on environmental surfaces. Poor hygiene in calf housing areas allows fecal-oral transmission between animals. Overcrowding concentrates pathogens and increases exposure. Inadequate ventilation and moist conditions favor bacterial survival and multiplication in the environment. Failure of cleaning and disinfection protocols between animal groups allows pathogen accumulation that overwhelms subsequently introduced neonates.

The most critical risk factor for colibacillosis development is failure of passive immunity transfer (FPT), occurring when neonates do not receive adequate colostral antibodies within the first hours of life. Colostrum contains immunoglobulins that protect against enteric pathogens during the first weeks before the animal's own immune system becomes functional. Calves that fail to receive sufficient colostrum of adequate quality within the first six to twelve hours face dramatically increased risk of colibacillosis and other neonatal diseases. Dam factors affecting colostrum quality, delayed first nursing, dystocia, and cold stress all contribute to FPT. Routine monitoring of passive transfer status through serum total protein or immunoglobulin measurement identifies at-risk animals requiring enhanced monitoring and care.

The pathophysiology of enteric colibacillosis involves bacterial colonization of the small intestine followed by toxin-mediated or attachment-effacement damage to the intestinal lining. Enterotoxigenic strains attach via fimbrial adhesins (F4, F5, F6, F41) and produce heat-stable and heat-labile enterotoxins that stimulate massive fluid secretion into the intestinal lumen. This hypersecretory diarrhea causes rapid dehydration and electrolyte loss. Enteropathogenic strains attach intimately to enterocytes, effacing the normal brush border and causing malabsorption and inflammation. Septicemic colibacillosis occurs when bacteria penetrate the intestinal barrier and enter the bloodstream, causing systemic inflammatory response, shock, and multiple organ failure. The specific pathotype involved influences clinical presentation, progression, and prognosis.

Early warning signs of colibacillosis appear rapidly in affected neonates, often within hours of birth or during the first days of life. Affected calves may show initial lethargy and reluctance to nurse before diarrhea becomes apparent, with decreased vigor and reduced suckling reflex. Subtle changes in behavior including remaining recumbent while herdmates are active, reduced responsiveness to stimuli, and depressed demeanor precede obvious clinical signs in some cases. Abdominal distension may develop early as intestinal fluid accumulation occurs. Careful observation of neonates during the first days of life enables recognition of these prodromal signs that prompt early intervention.

Common symptoms vary somewhat between species while sharing the hallmark feature of profuse diarrhea. Calves with enteric colibacillosis typically develop watery, yellow to white diarrhea (hence the historical name "white scours") that rapidly leads to dehydration. Feces may be projectile and extremely liquid, soiling the perineum, tail, and hind legs extensively. Lambs and kids display similar profuse watery diarrhea with rapid dehydration. Piglets develop yellow to gray liquid feces and become weak and hollow-appearing very quickly. In poultry, colibacillosis may present as respiratory disease, septicemia with sudden death, or enteric disease depending on the route of infection and bacterial strain involved.

Behavioral changes associated with colibacillosis reflect the profound systemic effects of dehydration and toxemia on affected neonates. Vigorous young animals become progressively weaker, first showing reluctance to stand, then inability to rise without assistance. Nursing behavior ceases as animals become too weak or debilitated to seek food. Depression deepens from mild lethargy to obtundation or semi-consciousness in severe cases. Some animals display signs of abdominal discomfort including vocalizing, stretching, or grinding teeth. Dehydration causes sunken eyes, providing a characteristic appearance that experienced producers immediately recognize. Hypothermia develops as dehydrated animals lose ability to maintain body temperature.

Physical examination findings in colibacillosis cases reveal the severity of fluid losses and systemic illness. Dehydration assessment shows decreased skin elasticity (skin tenting persisting for seconds), sunken eyes, dry mucous membranes, and prolonged capillary refill time exceeding three seconds in severe cases. Heart rate increases compensating for reduced circulating volume, with weak peripheral pulses palpable in advanced dehydration. Extremities become cold as peripheral circulation diminishes. Body temperature may be elevated initially with active infection, then falls below normal as cardiovascular collapse progresses. Abdominal auscultation reveals hypermotility early and reduced sounds as ileus develops. Fecal examination confirms watery, malodorous diarrhea often with distinctive color patterns.

Symptom progression in untreated colibacillosis moves rapidly toward death, with animals deteriorating over hours to one or two days. Initial mild depression and soft feces progress to profuse watery diarrhea with progressive dehydration. Weakness advances to recumbency as fluid losses exceed ten percent of body weight. Metabolic acidosis from bicarbonate losses contributes to cardiovascular dysfunction. Septicemic cases may progress even more rapidly, with sudden death occurring before significant diarrhea develops in some animals. Multi-organ failure develops in severe cases, with kidney damage from poor perfusion, respiratory distress, and neurological signs including seizures in terminal stages.

Emergency symptoms requiring immediate intervention include recumbency with inability to lift head, extreme dehydration evidenced by deeply sunken eyes and absent skin elasticity, cold extremities and weak or absent pulses, altered consciousness ranging from obtundation to coma, respiratory distress, and active seizure activity. Septicemic animals may present with sudden depression, high fever initially then hypothermia, rapid breathing, and purplish discoloration of extremities or ears. These presentations represent life-threatening emergencies requiring aggressive fluid therapy and antibiotic treatment for any chance of survival. Even with treatment, mortality is high once animals reach these critical stages.

Clinical examination of suspected colibacillosis cases evaluates hydration status, vital parameters, and fecal characteristics while gathering history regarding colostrum management and environmental conditions. Assessment of dehydration severity guides initial fluid therapy decisions and provides prognostic information. Rectal temperature identifies fever suggesting active infection versus hypothermia indicating cardiovascular collapse. Fecal character assessment notes consistency, color, odor, and presence of blood or mucus. Neurological evaluation detects signs of septicemia or metabolic derangement. History regarding age at symptom onset, colostrum intake, and other affected animals helps distinguish colibacillosis from other neonatal diarrhea causes.

Diagnostic testing confirms bacterial involvement and characterizes the causative strains. Fecal culture isolates E. coli and allows sensitivity testing to guide antibiotic selection, though turnaround time may exceed the treatment decision window in acute cases. Rapid antigen tests detect specific E. coli fimbrial types (K99/F5) from fecal samples, providing point-of-care diagnosis in calf scours cases. Polymerase chain reaction (PCR) testing identifies virulence genes associated with pathogenic strains. Blood culture is indicated in suspected septicemia to confirm systemic infection and guide treatment. Blood work reveals hemoconcentration from dehydration, metabolic acidosis, electrolyte derangements including hyponatremia and hyperkalemia, and elevated blood urea nitrogen. Serum total protein measurement assesses passive transfer status.

Differential diagnosis for neonatal diarrhea includes multiple pathogens and conditions producing similar presentations. Rotavirus and coronavirus cause profuse watery diarrhea in calves and may coinfect with E. coli. Cryptosporidiosis produces watery diarrhea typically in slightly older calves than peak E. coli susceptibility. Salmonellosis affects calves of various ages with bloody diarrhea and systemic signs. Clostridial enteritis causes acute severe disease that may be confused with colibacillosis. Nutritional scours from overfeeding or inappropriate milk replacer formulation produces diarrhea without systemic illness. In lambs, lamb dysentery (Clostridium perfringens type B) and watery mouth disease represent important differentials. Comprehensive diagnostic workup including multiple pathogen testing often reveals mixed infections.

Herd-level diagnostics become essential when colibacillosis affects multiple animals or recurs across calf crops. Necropsy examination of fatal cases provides tissue samples for culture and histopathology, confirming diagnosis and characterizing bacterial strains. Environmental sampling identifies contamination sources and guides sanitation interventions. Colostrum quality testing using colostrometer or Brix refractometer evaluates whether maternal factors contribute to passive transfer failure. Serum sampling of healthy calves monitors passive transfer success across the herd. Review of calving area management, colostrum protocols, and calf housing practices identifies deficiencies requiring correction. Veterinary consultation synthesizes diagnostic information into actionable herd health recommendations.

Emergency treatment for colibacillosis prioritizes rapid fluid replacement to correct life-threatening dehydration and electrolyte imbalances. Intravenous fluid administration is essential for moderately to severely dehydrated animals, with isotonic crystalloid solutions (saline, lactated Ringer's) given at aggressive rates calculated to replace estimated deficits plus ongoing losses over twelve to twenty-four hours. Sodium bicarbonate supplementation may be necessary for severe metabolic acidosis. Warm fluids help address hypothermia in collapsed animals. Oral electrolyte solutions supplement intravenous therapy and may suffice alone for mild cases with intact nursing reflex. Feeding should continue during treatment, as continued milk intake supports intestinal recovery and does not worsen diarrhea when appropriate oral rehydration is provided.

Antibiotic therapy addresses bacterial infection and is indicated for most colibacillosis cases, particularly those with systemic signs suggesting septicemia risk. Drug selection should consider likely E. coli sensitivity patterns on the specific farm, as resistance is common and varies regionally. Commonly used antibiotics include aminoglycosides (gentamicin, amikacin), fluoroquinolones (enrofloxacin where legal and appropriate), potentiated sulfonamides, and third-generation cephalosporins. Local treatment with oral aminoglycosides may suffice for uncomplicated enteric disease, while systemic antibiotics are essential for septicemia or severely compromised animals. Culture and sensitivity results guide treatment adjustment when initial empiric therapy appears ineffective. Withdrawal times for all antibiotics must be strictly observed in food animals.

Supportive care measures significantly influence treatment outcomes beyond fluids and antibiotics. Nutritional support through continued milk feeding provides calories and promotes intestinal epithelial recovery, contrary to historical recommendations for withholding milk. Providing dry, clean bedding and warm environment prevents further heat loss in compromised animals. Pain management improves comfort and may enhance recovery, with options limited by food animal restrictions. Anti-inflammatory therapy (flunixin meglumine) addresses endotoxemia effects in septicemic cases while respecting withdrawal requirements. Probiotic supplementation may support intestinal flora restoration during recovery. Isolation of affected animals prevents transmission to healthy neonates while allowing intensive individual monitoring and care.

Herd treatment protocols address outbreak situations affecting multiple animals. Metaphylactic antibiotic treatment of at-risk animals (all neonates born during an outbreak period) may reduce clinical disease incidence. Enhanced environmental sanitation interrupts ongoing transmission. Emergency vaccination of dams approaching parturition may boost colostral antibody levels for subsequent offspring. Review and intensification of colostrum management protocols ensures all neonates receive adequate passive immunity. Increased monitoring allows earlier case detection and treatment initiation. Veterinary guidance helps balance treatment aggressiveness against antimicrobial stewardship concerns.

Surgical intervention is not applicable for colibacillosis itself, though supportive surgical procedures may occasionally be necessary. Intravenous catheter placement facilitates fluid administration in severely dehydrated animals requiring extended treatment. Umbilical infections occurring as complications of septicemia may require surgical drainage or resection.

Treatment decisions in colibacillosis management involve balancing individual animal welfare and economic considerations. Mild cases identified early respond well to oral fluid therapy with or without antibiotics and carry good prognosis. Severe cases requiring intensive intravenous fluid therapy, extended treatment, and hospitalization may exceed economic value of individual animals in commercial settings. However, treatment provides welfare benefits and prevents potential source animals from contaminating the environment. Euthanasia is appropriate for animals failing to respond to aggressive therapy or those presenting with irreversible shock, preventing unnecessary suffering while acknowledging treatment limitations.

Recovery timelines for colibacillosis vary considerably based on disease severity at treatment initiation and presence of complications. Mildly affected animals treated promptly may show improved hydration and reduced diarrhea within twenty-four to forty-eight hours, with return to normal fecal consistency over three to five days. Moderately affected animals require longer recovery periods extending one to two weeks, with gradual improvement in appetite, hydration, and fecal character. Severely affected animals surviving initial treatment may require weeks of continued care before full recovery, with persistent weakness and poor growth during the convalescent period. Some survivors experience lasting impacts on growth and development.

Post-treatment care focuses on nutritional support and prevention of secondary complications during the recovery phase. Continued milk feeding at normal volumes supports caloric needs and intestinal epithelial recovery, with gradual introduction of solid feeds as age-appropriate. Clean, dry bedding maintained throughout recovery prevents recontamination and secondary infections. Monitoring for complications including secondary respiratory disease, umbilical infections, or joint ill (septic arthritis) enables early intervention when problems develop. Gradual return to group housing occurs once animals are fully recovered, eating normally, and no longer shedding high pathogen levels in feces.

Prognostic factors influencing recovery outcomes include age at infection, severity at treatment initiation, passive transfer status, presence of septicemia, and development of complications. Animals with adequate passive immunity experiencing mild enteric disease have excellent prognosis for complete recovery. Those with failure of passive transfer face higher mortality and greater risk of lasting impacts. Septicemic animals carry guarded prognosis even with aggressive treatment. Delay in treatment initiation dramatically worsens outcomes, emphasizing importance of early detection and intervention. Multi-organ damage from severe septicemia or prolonged shock may cause irreversible harm affecting long-term survival and productivity.

Return to production considerations guide management decisions for recovered colibacillosis cases. Surviving animals should be monitored for growth rate compared to unaffected contemporaries, with significant lag potentially indicating lasting intestinal damage or secondary problems. Breeding value is not directly affected by individual colibacillosis history, though repeated disease in offspring may suggest maternal factors (poor colostrum quality) warranting evaluation. Animals recovered from neonatal scours can achieve normal production as adults, though early growth setbacks may persist. Economic analysis comparing recovery costs against animal value guides retention versus culling decisions for animals with significant lasting impacts.

Vaccination protocols form a cornerstone of colibacillosis prevention, focusing on dam vaccination to enhance colostral antibody transfer to neonates. Scour vaccines containing E. coli bacterins with relevant fimbrial antigens (K99/F5, F41, F6) are administered to pregnant dams during late gestation, typically three to six weeks before expected parturition. This timing allows antibody production and concentration in colostrum for transfer at first nursing. Annual revaccination maintains immunity in the breeding herd. Vaccine selection should include locally relevant E. coli strains, with veterinary guidance on products appropriate for specific operation disease patterns. Calf vaccination may provide additional protection but is less established than maternal immunization approaches.

Biosecurity measures targeting colibacillosis focus on reducing environmental contamination and pathogen exposure during the vulnerable neonatal period. Clean, dry calving areas with fresh bedding for each parturition minimize immediate postnatal exposure. Separation of calving areas from calf housing prevents transmission from older carriers to newborns. All-in-all-out management of calf facilities with thorough cleaning and disinfection between groups breaks infection cycles. Hand hygiene and boot disinfection protocols prevent human-mediated transmission between animals and areas. Isolation of sick animals limits environmental contamination and protects healthy neonates.

Colostrum management represents the single most important preventive intervention for colibacillosis and other neonatal diseases. Ensuring that every calf receives adequate colostrum of good quality within the first hours of life provides passive immunity against E. coli and other pathogens. Target colostrum intake is ten percent of body weight (approximately four liters for Holstein calves) within six hours of birth. Quality assessment using colostrometer or Brix refractometer identifies inadequate colostrum requiring supplementation or replacement. Heat treatment of colostrum (sixty degrees Celsius for sixty minutes) reduces bacterial contamination while preserving antibody function. Colostrum banking through proper storage and management ensures availability for calves from dams with inadequate production.

Management practices supporting colibacillosis prevention span calving assistance through calf housing. Prompt, sanitary assistance at difficult births reduces calf stress and contamination exposure. Navel dipping with antiseptic solution (dilute chlorhexidine or iodine) immediately after birth prevents bacterial entry through the umbilical stump. Comfortable environmental temperatures reduce stress and energy expenditure that compromise immune function. Appropriate calf densities prevent overcrowding and excessive fecal contamination. Consistent feeding schedules and appropriate nutrition support immune competence and intestinal health.

Quarantine and testing protocols contribute to colibacillosis prevention through monitoring and early intervention. Routine monitoring of serum total protein in calves at twenty-four to forty-eight hours of age identifies passive transfer failure requiring enhanced monitoring and potentially preventive treatment. Fecal pathogen testing during outbreaks identifies causative strains and guides prevention adjustments. Necropsy examination of neonatal mortality provides diagnostic information valuable for herd prevention programs. New animal introductions, particularly pregnant females, may warrant quarantine to prevent introduction of novel pathogenic strains. Veterinary consultation integrates testing results with management recommendations for comprehensive prevention programs.

Daily management practices significantly impact colibacillosis risk in livestock operations raising young stock. Consistent feeding schedules and volumes prevent nutritional stress that may compromise intestinal defenses. Clean feeding equipment (nipples, bottles, buckets) prevents bacterial transmission during feeding. Fresh, clean water availability supports hydration and normal intestinal function. Daily observation of all neonates identifies early clinical signs enabling prompt intervention. Bedding maintenance through regular addition of clean material and removal of soiled areas reduces environmental pathogen loads. Temperature monitoring ensures housing remains appropriate for neonatal thermoregulation.

Housing and environmental management create conditions either favoring or inhibiting E. coli transmission. Adequate space allocation prevents overcrowding and excessive fecal contamination. Dry, well-ventilated facilities discourage bacterial survival and multiplication in the environment. Regular cleaning schedules appropriate for facility type maintain hygiene between animal groups. Drainage systems prevent standing water and moisture accumulation that favor pathogens. Separation of age groups prevents transmission from older shedding animals to susceptible neonates. Isolation facilities enable separation and intensive care of sick individuals without contaminating general housing.

Herd health programs incorporating colibacillosis prevention integrate vaccination, colostrum management, and environmental protocols. Veterinary consultation establishes vaccination schedules appropriate for specific operation disease risks and timing. Colostrum management protocols ensure consistent quality and quantity delivery to all neonates. Environmental sanitation standards define cleaning frequencies and methods maintaining acceptable hygiene. Monitoring programs track passive transfer success, disease incidence, and mortality rates to assess prevention effectiveness. Regular review and adjustment of protocols maintains prevention performance as conditions change. Integration with other calf health programs addresses the full spectrum of neonatal disease risks.

Record keeping supports colibacillosis prevention through documentation of disease occurrence, treatment responses, and prevention program compliance. Individual calf records track birth conditions, colostrum intake, passive transfer status, and health events. Mortality records with necropsy results identify patterns suggesting prevention gaps. Vaccination records confirm dam immunization status and timing. Environmental cleaning logs document protocol compliance. Cost tracking for neonatal disease losses and prevention expenditures supports economic decision-making regarding program investments. Production records comparing performance of calves from different protocols enable continuous improvement.

Economic considerations drive colibacillosis prevention investments across livestock operations. Neonatal mortality represents direct and significant financial loss, with replacement costs and lost production potential exceeding prevention program expenses in most cases. Subclinical impacts on growth and development compound economic effects of clinical disease. Prevention program costs including vaccines, colostrum testing equipment, and enhanced labor require justification through reduced losses. Cost-benefit analysis of different prevention components helps prioritize limited resources. Veterinary consultation provides expertise in designing economically efficient prevention programs appropriate for specific operation scales and circumstances.

No specific livestock breeds demonstrate increased genetic susceptibility to colibacillosis, as the disease affects all breeds based primarily on management factors and passive immunity status rather than inherent breed characteristics. However, management differences between breed types may create apparent associations with disease incidence. Dairy breeds, particularly Holsteins, experience high colibacillosis rates partly due to typical management involving immediate separation from dams that may compromise colostrum intake. Beef breeds with natural nursing under extensive management may achieve better passive transfer but face environmental challenges in adverse weather conditions. Within species, any breed can experience colibacillosis when prevention practices fail to ensure adequate passive immunity and hygiene.

Production type significantly influences colibacillosis risk through associated management intensity and practices. Dairy calf rearing operations with artificial colostrum delivery must ensure protocol compliance for adequate passive transfer. Veal operations receiving transported newborn calves face compounded stress and potential passive transfer failure. Beef operations using natural nursing may achieve good passive transfer but face weather exposure risks. Intensive swine operations with early weaning create vulnerability periods for enteric disease. Commercial poultry operations with hatchery-derived chicks face colibacillosis risks from early environmental exposure. Understanding production-type-specific risk factors enables targeted prevention program design.

Genetic selection for colibacillosis resistance is not currently practiced commercially, though research has identified genetic variation in susceptibility. Some work has examined intestinal receptor expression that affects E. coli attachment, but practical genetic markers for selection have not been implemented. Selection for general immune competence and disease resistance may indirectly favor animals with enhanced colibacillosis resistance. Dam genetic factors affecting colostrum quality and quantity influence offspring protection, representing an indirect genetic contribution to disease susceptibility. Future developments may enable selection for specific resistance factors, but current prevention relies on management practices rather than genetic approaches.

Commonly co-occurring conditions with colibacillosis include other neonatal pathogens affecting young livestock during the same vulnerable period. Rotavirus and coronavirus frequently coinfect with E. coli, causing combined viral-bacterial diarrhea that may be more severe than either pathogen alone. Cryptosporidiosis often follows or accompanies bacterial scours in calves, with overlapping clinical presentations. Salmonellosis may complicate E. coli infection or present as the primary pathogen. Clostridial enterotoxemia can develop rapidly in animals with disturbed intestinal flora from any cause. Failure of passive transfer, while not a disease itself, commonly underlies susceptibility to colibacillosis and multiple other neonatal conditions simultaneously.

Conditions with similar symptoms to colibacillosis require differentiation for appropriate treatment selection. Viral enteritis (rotavirus, coronavirus) produces watery diarrhea in calves but does not respond to antibiotics, requiring supportive care focus. Cryptosporidiosis causes diarrhea typically in slightly older calves and resists most treatments. Salmonellosis may be clinically indistinguishable but carries zoonotic implications and may require different antibiotic selection. Nutritional scours from overfeeding or inappropriate milk replacer produces diarrhea without systemic illness and resolves with dietary management. Coccidiosis affects older animals than typical colibacillosis and requires anticoccidial rather than antibiotic treatment. Comprehensive diagnostic testing often reveals mixed infections requiring multi-targeted therapy.

Complications and sequelae of colibacillosis extend impacts beyond the acute enteric infection. Septicemia represents the most serious complication, with systemic bacterial invasion causing multi-organ failure and high mortality. Joint ill (septic arthritis) develops when bacteria localize in joints, causing permanent damage requiring prolonged treatment. Meningitis may occur in septicemic animals, carrying grave prognosis. Umbilical infections and abscesses develop from bacterial invasion through the navel. Chronic intestinal damage from severe disease may cause lasting malabsorption affecting growth and development. Respiratory disease may develop concurrently or as a sequela in weakened animals. Understanding these potential complications emphasizes the importance of early treatment and aggressive supportive care.